ABT - Abbott Laboratories

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue30,578,00027,390,00020,853,00020,405,000
Cost of Revenue12,659,00011,490,0009,085,0008,729,000
Gross Profit17,919,00015,900,00011,768,00011,676,000
Operating Expenses
Research Development2,288,0002,183,0001,442,0001,371,000
Selling General and Administrative9,531,0008,804,0006,558,0006,742,000
Non Recurring----
Others----
Total Operating Expenses26,656,00024,452,00017,635,00017,443,000
Operating Income or Loss3,922,0002,938,0003,218,0002,962,000
Income from Continuing Operations
Total Other Income/Expenses Net-1,049,000-707,000-1,805,000221,000
Earnings Before Interest and Taxes3,922,0002,938,0003,218,0002,962,000
Interest Expense-826,000-904,000-431,000-163,000
Income Before Tax2,873,0002,231,0001,413,0003,183,000
Income Tax Expense539,0001,878,000350,000577,000
Minority Interest198,000201,000179,000115,000
Net Income From Continuing Ops2,334,000353,0001,063,0002,606,000
Non-recurring Events
Discontinued Operations34,000124,000337,0001,817,000
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income2,368,000477,0001,400,0004,423,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares2,353,000468,0001,393,0004,403,000